Abstract
Liver transplantation is the most effective treatment for treating liver cirrhosis. However, a limited number of donors, graft rejection, and other complications can undermine transplant success. It is considered that cell transplantation is an alternative approach of liver transplantation. We previously developed a protocol for hepatic differentiation of cluster of differentiation 117+ stem cells isolated from human exfoliated deciduous tooth pulp (SHEDs) under hydrogen sulfide exposure. These cells showed excellent hepatic function. Here, we investigated whether hepatocyte-like cell transplantation is effective for treating carbon tetrachloride (CCl4)-induced liver cirrhosis. SHEDs were hepatically differentiated, which was confirmed via immunological analyses and albumin concentration determination in the medium. Rats were intraperitoneally injected with CCl4 for and the differentiated cells were injected into rat spleen. Histopathological and immunohistochemical analyses were performed. Liver functions were serologically and pathologically determined. Quantitative real-time-polymerase chain reaction was implemented to clarify the treatment procedure of liver cirrhosis. In vitro-differentiated hepatocyte-like cells were positive for all examined hepatic markers. SHED-derived hepatocyte transplantation eliminated liver fibrosis and restored liver structure in rats. Liver immunohistochemical analyses showed the presence of human-specific hepatic markers, i.e., a large amount of human hepatic cells were very active in the liver and spleen. Serological tests revealed significant liver function recovery in the transplantation group. Expression of genes promoting fibrosis increased after cirrhosis induction but was suppressed after transplantation. Our results suggest that xenotransplantation of hepatocyte-like cells of human origin can treat cirrhosis. Moreover, cell-based therapy of chronic liver conditions may be an effective option.
Similar content being viewed by others
References
Murray KF, Carithers RL Jr. AASLD. AASLD practice guideline: evaluation of the patient for liver transplantation. Hepatology. 2005;41:1407–32.
Lo CM. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation. 2003;75:12-5.
Feldmann G. Liver transplantation of hepatic stem cells: potential use for treating liver diseases. Cell Biol Toxicol. 2001;17:77–85.
Nakamura T, Koga H, Iwamoto H, et al. Ex vivo expansion of circulating CD34(+) cells enhances the regenerative effect on rat liver cirrhosis. Mol Ther Methods Clin Dev. 2016;3:16025.
Crowder SW, Horton LW, Lee SH, et al. Passage-dependent cancerous transplantation of human mesenchymal stem cells under carcinogenic hypoxia. FASEB J. 2013;27:2788–98.
Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897–904.
Zhu W, Xu W, Jiang R, et al. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol. 2006;80:267–74.
Akay I, Oxmann D, Helfenstein A, et al. Tumor risk by tissue engineering: cartilaginous differentiation of mesenchymal stem cells reduces tumor growth. Osteoarthritis Cartilage. 2010;18:389–96.
Ishkitiev N, Yaegaki K, Calenic B, et al. Deciduous and permanent dental pulp mesenchymal cells acquire hepatic morphologic and functional features in vitro. J Endod. 2010;36:469–74.
Ishkitiev N, Yaegaki K, Imai T, et al. High-purity hepatic lineage differentiated from dental pulp stem cells in serum-free medium. J Endod. 2012;38:475–80.
Ishkitiev N, Calenic B, Aoyama I, Ii H, Yaegaki K, Imai T. Hydrogen sulfide increases hepatic differentiation tooth pulp stem cells. J Breath Res. 2012;6:017103.
Okada M, Ishkitiev N, Yaegaki K, et al. Hydrogen sulfide increases hepatic differentiation of human tooth pulp stem cells compared with human bone marrow stem cells. Int Endod J. 2014;47:1142–50.
Bain BJ. Bone marrow aspiration. J Clin Pathol. 2001;54:657–63.
Bain BJ. Bone marrow biopsy morbidity: review of 2003. J Clin Pathol. 2005;58:406–8.
Chahla J, Mannava S, Cinque ME, Geeslin AG, Codina D, LaPrade RF. Bone marrow aspirate concentrate harvesting and processing technique. Arthrosc Tech. 2017;6:e441-5.
Miura M, Gronthos S, Zhao M, et al. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA. 2003;100:5807–12.
Hirata TM, Ishkitiev N, Yaegaki K, et al. Expression of multiple stem cell markers in dental pulp cells cultured in serum-free media. J Endod. 2010;36:1139–44.
Ishkitiev N, Yaegaki K, Imai T, et al. Novel management of acute or secondary biliary liver conditions using hepatically differentiated human dental pulp cells. Tissue Eng Part A. 2014;21:586–93.
Michalopoulos GK, Bowen WC, Mulè K, Luo J. HGF- EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures. Gene Expr. 2003;11:55–75.
Suzuki A, Iwama A, Miyashita H, Nakauchi H, Taniguchi H. Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells. Development. 2003;130:2513–24.
Kamiya A, Gonzalez FJ. TNF-alpha regulates mouse fetal hepatic maturation induced by oncostatin M and extracellular matrices. Hepatology. 2004;40:527–36.
Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;102:538–49.
Jiang Y, Wang C, Li YY, et al. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference. J Ethnopharmacol. 2014;158(Pt A):230–38.
Svingen T, Letting H, Hadrup N, Hass U, Vinggaard AM. Selection of reference genes for quantitative RT-PCR (RT-qPCR) analysis of rat tissues under physiological and toxicological conditions. PeerJ. 2015;3:e855.
Rockey DC, Weymouth N, Shi Z. Smooth muscle α actin (Acta2) and myofibroblast function during hepatic wound healing. PLoS One. 2013;8:e77166.
Frommel TO, Yong S, Zarling EJ. Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. Am J Gastroenterol. 1999;94:178–82.
Pham BN, Bemuau J, Durand F, et al. Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease. J Hepatol. 2001;34:537–47.
Tan Q, Hu J, Yu X, et al. The role of IL-1 family members and Kupffer cells in liver regeneration. Biomed Res Int. 2016; 2016:6495793.
Cholongitas E, Marelli L, Shusang V, et al. A systematic review of the performance of the model for and-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006;12:1049–61.
Elkholy S, Mogawer S, Hosny A, et al. Predictors of mortality in living donor liver transplantation. Transplant Proc. 2017; 49:1376–82.
Berglund D, Kirchner V, Pruett T, et al. Complications after living donor hepatectomy: analysis of 176 cases at a single center. J Am Colloid Surg. 2018;227:24–36.
Wakade VA, Mathur SK. Donor safety in live-related liver transplantation. Indian J Surg. 2012;74:118–26.
Kling CE, Perkins JD, Reyes JD, Montenovo MI. Living donation versus donation after circulatory death liver transplantation for low MELD recipients. Liver Transpl. 2018. https://doi.org/10.1002/lt.25073.
Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006;24:2292–98.
Nakamura T, Torimura T, Iwamoto H, et al. CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis. J Gastroenterol Hepatol. 2014;29:1830–8.
Baumann U, Crosby HA, Ramani P, Kelly DA, Strain AJ. Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell? Hepatology. 1999;30:112–7.
Ishkitiev N, Yaegaki K, Kozhuharova A, et al. Pancreatic differentiation of human dental pulp CD117+ stem cells. Regen Med. 2013;8:597–612.
Okada M, Imai T, Yaegaki K, Ishkitiev N, Tanaka T. Regeneration of insulin-producing pancreatic cells using a volatile bioactive compound and human teeth. J Breath Res. 2014;8:046004.
Takebe T, Sekine K, Enomura M, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013;499:481–4.
Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: from liver transplantation to cell factory. J Hepatol. 2015;62:157–69.
Sakaida I, Terai S, Yamamoto N, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004;40:1304–11.
Asgari S, Moslem M, Bagheri-Lankarani K, Pournasr B, Miryounesi M, Baharvand H. Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells. Stem Cell Rev. 2013;9:493–504.
Raafat N, Abdel Aal SM, Abdo FK, El Ghonaimy NM. Mesenchymal stem cells: In vivo therapeutic application ameliorates carbon tetrachloride induced liver fibrosis in rats. Int J Biochem Cell Biol. 2015;68:109–18.
Mandal A, Viswanathan C. Natural killer cells: In health and disease. Hematol Oncol Stem Cell Ther. 2015;8:47–55.
Moriya K, Yoshikawa M, Saito K, et al. Embryonic stem cells develop into hepatocytes after intrasplenic transplantation in CCl4-treated mice. World J Gastroenterol. 2007;13:866–73.
Okumoto K, Saito T, Haga H, et al. Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of transplanted cells in the injured liver. J Gastroenterol. 2006;41:62–9.
Xue G, Han X, Ma X, et al. Effect of microenvironment on differentiation of human umbilical cord mesenchymal stem cells into hepatocytes in vitro and in vivo. Biomed Res Int. 2016; 2016:8916534.
Adinolfi A, Adinolfi M, Lessof MH. Alpha-feto-protein during development and in disease. J Med Genet. 1975;12:138–51.
Ma R, Chen J, Li Z, Tang J, Wang Y, Cai X. Decorin accelerates the liver regeneration after partial hepatectomy in fibrotic mice. Chin Med J (Engl). 2014;127:2679–85.
Kong X, Horiguchi N, Mori M, Gao B. Cytokines and STATs in liver fibrosis. Front Physiol. 2012;3:69.
Luedde T, Schwabe RF. NF-κB in the liver–linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:108–18.
Xu F, Liu C, Zhou D, Zhang L. TGF-β/SMAD Pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 2016;64:157–67.
Zheng K, Cubero FJ, Nevzorova YA. c-MYC-making liver sick: role of c-MYC in hepatic cell function, homeostasis and disease. Genes (Basel). 2017;8(4):E123.
Li Y, Turpin CP, Wang S. Role of thrombospondin 1 in liver diseases. Hepatol Res. 2017;47:186–93.
Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014;20:7312–24.
Acknowledgements
This study was funded by the Nippon Dental University. We also thank Masanori Nasu and Tetsuro Horie, Research Center for Odontology, School of Life Dentistry, Nippon Dental University.
Funding
This study was partially funded by Research Project No. 3 from Nippon Dental University, Tokyo, Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee of Nippon Dental University School of Life Dentistry at Tokyo as well as the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants and their parents/LAR included in the study. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yokoyama, T., Yagi Mendoza, H., Tanaka, T. et al. Regulation of CCl4-induced liver cirrhosis by hepatically differentiated human dental pulp stem cells. Human Cell 32, 125–140 (2019). https://doi.org/10.1007/s13577-018-00234-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13577-018-00234-0